Utama › Nefrosis Lipoid › California
Kajian klinikal Nefrosis Lipoid di California
4 kajian untuk Nefrosis Lipoid sedang mencari peserta di lokasi di California.
Bandar di California
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- University of California Irvine Medical Center- Site Number : 8400015, Orange
- University of California San Francisco - Parnassus Heights- Site Number : 8400012, San Francisco
Mengambil pesertaFasa 2
Umur 16 hingga 75 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06500702Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Academic Medical Research Institute, Los Angeles
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06466135Nephrotic Syndrome Study Network
- University of Southern California-Children's Hospital, Los Angeles
- Stanford University School of Medicine, Palo Alto
- University of California San Francisco Benioff Children's Hospitals, San Francisco
- dan 1 lagi
Mengambil pesertaKajian pemerhatian
Sehingga umur 80 · Semua jantina · Dikemas kini 10 Jun 2026 · NCT01209000Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Cedars-Sinai Medical Center, Los Angeles
Mengambil pesertaFasa 2
Umur 1 hingga 17 · Semua jantina · Dikemas kini 12 Mei 2026 · NCT05003986Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.